Procurement Summary
Country: USA
Summary: Clinical Trials to Test Artificial Pancreas Device Systems in Populations Challenging to Manage Type 1 Diabetes (T1D) (U01 Clinical Trial Required)
Deadline: 09 Apr 2020
Posting Date: 05 Dec 2019
Other Information
Notice Type: Tender
TOT Ref.No.: 38612037
Document Ref. No.: RFA-DK-19-036
Competition: ICB
Financier: Self Financed
Purchaser Ownership: -
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Tender are invited for Clinical Trials to Test Artificial Pancreas Device Systems in Populations Challenging to Manage Type 1 Diabetes (T1D) (U01 Clinical Trial Required)
CFDA Number : 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement : No
Estimated Total Program Funding : $3, 000, 000
Closing Date for Applications: Apr 09, 2020
Posted Date : Dec 04, 2019
Description: This FOA will support the conduct of clinical trials designed to test the clinical safety and efficacy of artificial pancreas (AP) device systems with the objective of improving glycemic control, reducing acute complications and improving quality of life in people with difficult to control T1D when using standard of care therapies.
Documents
Tender Notice